Most Read News

On 1 December 2022

Biocon announced that with reference to the proposed acquisition of biosimilars assets of Viatris Inc., by Biocon Biologics (BBL), subsidiary of Biocon, BBL has allotted equity shares to Biocon for an amount of Rs. 2,205.63 crore (~US$ 270 Million) on 23 November 2022. Post allotment, Biocons stake in BBL will be 88.85%. Powered by Capital Market – Live News

Gland Pharma has allotted 1,800 Equity shares of Re.1/- each of the Company, fully paid up, on 24 November 2022 to employee(s) on exercise of their Stock Options pursuant to Gland Pharma Employee Stock Options Scheme, 2019. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,690,223 /- comprising of 164,690,223 Equity shares of face value Re.1/- eachPowered by […]

Angel One has allotted 5617 equity shares under ESOP on 24 November 2022. With this allotment, the paid up equity share capital stands at Rs 83,36,73,770 comprising of 8,33,67,377 equity shares of face value of Rs. 10 each. Powered by Capital Market – Live News

Wipro has allotted 1,51,837 equity shares under ADS Restricted Stock Unit Plan 2004 on 23 November 2022 pursuant to exercise of ESOPs. Powered by Capital Market – Live News

On 29 November 2022

On 2 December 2022

With effect from 25 November 2022

The Singapore stock market finished session lower on Thursday, 24 November 2022, even as regional indices rose after minutes from the US Federal Reserve signalled it could slow its rate hikes, weighed down by losses in financials and consumer goods stocks. At closing bell, the Straits Times Index (STI) index was down 3.11 points or 0.1% to 3,252.88 after trading between 3,250.15 and 3,273.43. Volume […]

With effect from 24 November 2022